Chicago, Illinois — November 25, 2025 — Leads & Copy — New data regarding Hologic’s breast cancer detection technologies will be presented at the Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting in Chicago.
Hologic’s 3DQuorum® imaging technology and Genius AI® Detection solution are among the innovations to be showcased. The company will also host medical education events on AI, contrast-enhanced mammography (CEM), and breast surgery.
Mark Horvath, President of Breast & Skeletal Health Solutions at Hologic, stated the company is dedicated to advancing technologies that support women’s breast health at every stage. Horvath also mentioned that artificial intelligence is an increasingly critical tool in mammography, and Hologic is encouraged by data from multiple studies that underscore its potential to help radiologists work more efficiently without sacrificing quality.
One study, led by Dr. Manisha Bahl from Massachusetts General Hospital and Harvard Medical School, evaluated Hologic’s 3DQuorum® imaging technology using over 160,000 screening mammography exams. The study compared cancer detection rates before and after adopting 3DQuorum imaging technology, which uses AI to reduce the number of 3D imaging “slices” radiologists need to review without compromising image quality, sensitivity, or accuracy. The technology condenses a 60-page book into a 10-page summary that retains all relevant information and highlights key findings.
The results showed no significant difference in cancer detection rates after implementing 3DQuorum, suggesting the technology’s potential to streamline radiologists’ workflows and save time while maintaining high effectiveness in detecting cancers, according to the press release.
Dr. Bahl said that AI holds boundless potential in healthcare with a wide range of applications that can improve patient care. She noted that technologies like 3DQuorum help radiologists work more efficiently while delivering the same high-quality care. By streamlining the review process, AI allows radiologists to focus their attention where it matters most: finding cancers early and supporting each patient with confidence.
Another study, led by Professor Yan Chen from the University of Nottingham, U.K., compared Hologic’s Genius AI® Detection solution with radiologists. In this study, 108 radiologists from the U.K. and U.S. reviewed 75 challenging breast cancer cases, and the AI system assessed the same cases.
The AI technology performed similarly to radiologists. It detected more cancers but also showed lower specificity, meaning it could flag more false positives. These initial findings indicate that AI could help radiologists manage workloads in settings where double reading by multiple radiologists is required but staffing may be limited.
Hologic will also showcase its latest innovations at RSNA, including the AI-powered Genius AI Detection suite of products, leading breast surgery technologies, and the next-generation Envision™ Mammography Platform with tilt positioning designed to adapt to patients.
More information about Hologic’s presence at RSNA can be found at https://www.hologic.com/rsna.
Hologic’s Genius AI Detection solution is designed to locate lesions likely representing breast cancer and highlights suspicious areas at radiologists’ workstations for concurrent reading to support smart, decisive interpretation.
To learn more about Hologic, visit Genius AI™ Detection Technology | Hologic.
Hologic, 3DQuorum, Envision and Genius AI are trademarks and/or registered trademarks of Hologic, Inc.
References:
- Report: CSR-00116
- FDA Submission: P080003/S008
- Hologic data on file: DHM-16430
Contact:
Source: Hologic
